A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines

NCT05933512 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
SARS-CoV-2 Infection

Interventions

BIOLOGICAL: SCTV01E-2
BIOLOGICAL: SCTV01E

Sponsor

Sinocelltech Ltd.